| Trial ID: | L2169 |
| Source ID: | NCT00400491
|
| Associated Drug: |
Cholecalciferol (Vitamin D)
|
| Title: |
Vitamin D Supplementation to Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Cholecalciferol (vitamin D)|DRUG: Placebo
|
| Outcome Measures: |
Primary: glycated hemoglobin, 6 months | Secondary: blood pressure, 6 months|body weight, 6 months|Hip/waist ratio, 6 months|lipids, 6 months|Hs-CRP, 6 months|insulin sensitivity, 6 months
|
| Sponsor/Collaborators: |
Sponsor: University of Tromso
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-06
|
| Completion Date: |
2007-09
|
| Results First Posted: |
|
| Last Update Posted: |
2008-05-23
|
| Locations: |
Clinical Research Unit, University Hospital of North Norway, Tromsø, 9038, Norway
|
| URL: |
https://clinicaltrials.gov/show/NCT00400491
|
